168 related articles for article (PubMed ID: 38736892)
1. Triglyceride-inflammation score established on account of random survival forest for predicting survival in patients with nasopharyngeal carcinoma: a retrospective study.
Li J; Ye Y; Cai Y; Ji H; Qin W; Luo Y; Zhou X; Zhang Z; Xiao X; Zhang B
Front Immunol; 2024; 15():1375931. PubMed ID: 38736892
[TBL] [Abstract][Full Text] [Related]
2. Combined pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts survival and prognosis in patients with non-metastatic nasopharyngeal carcinoma: a retrospective study.
Yang D; Li P; Meng Z; Hu X; Huang Z; Huang H; Dong H; Qin Y; Chen C; Chen X; Li Z; Zhou Z; Li Y; Kang M
Sci Rep; 2024 Apr; 14(1):9898. PubMed ID: 38688967
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of immune inflammation-based index for predicting the clinical outcome in patients with nasopharyngeal carcinoma.
Zeng X; Liu G; Pan Y; Li Y
J Cell Mol Med; 2020 Aug; 24(15):8326-8349. PubMed ID: 32603520
[TBL] [Abstract][Full Text] [Related]
4. An inflammatory biomarker-based nomogram to predict prognosis of patients with nasopharyngeal carcinoma: an analysis of a prospective study.
Li XH; Chang H; Xu BQ; Tao YL; Gao J; Chen C; Qu C; Zhou S; Liu SR; Wang XH; Zhang WW; Yang X; Zhou SL; Xia YF
Cancer Med; 2017 Jan; 6(1):310-319. PubMed ID: 27860387
[TBL] [Abstract][Full Text] [Related]
5. A Novel Inflammation-Based Stage (I Stage) Predicts Overall Survival of Patients with Nasopharyngeal Carcinoma.
Li JP; Chen SL; Liu XM; He X; Xing S; Liu YJ; Lin YH; Liu WL
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27854304
[TBL] [Abstract][Full Text] [Related]
6. A novel prognostic model predicts overall survival in patients with nasopharyngeal carcinoma based on clinical features and blood biomarkers.
Lai C; Zhang C; Lv H; Huang H; Ke X; Zhou C; Chen H; Chen S; Zhou L
Cancer Med; 2021 Jun; 10(11):3511-3523. PubMed ID: 33973727
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model].
Zhang L; Shi FY; Qin Q; Liu GX; Zhang HW; Yan J; Tan M; Wang LZ; Xue D; Hu CH; Zhang Z; She JJ
Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):402-409. PubMed ID: 35615796
[No Abstract] [Full Text] [Related]
8. [Establishment and verification of a prognostic nomogram for survival of tongue squamous cell carcinoma patients who underwent cervical dissection].
Su J; Wang X; Sun Z
Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Feb; 56(1):120-130. PubMed ID: 38318906
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of the ratio of neutrophils to lymphocytes before and after intensity modulated radiotherapy for patients with nasopharyngeal carcinoma.
Liu J; Wei C; Tang H; Liu Y; Liu W; Lin C
Medicine (Baltimore); 2020 Jan; 99(2):e18545. PubMed ID: 31914029
[TBL] [Abstract][Full Text] [Related]
10. Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics.
Li J; Chen S; Peng S; Liu Y; Xing S; He X; Chen H
Int J Biol Sci; 2018; 14(5):549-556. PubMed ID: 29805306
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of nomogram based on SIRI for predicting the clinical outcome in patients with nasopharyngeal carcinomas.
Chen Y; Jiang W; Xi D; Chen J; Xu G; Yin W; Chen J; Gu W
J Investig Med; 2019 Mar; 67(3):691-698. PubMed ID: 30127099
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Significance of Neutrophil to Lymphocyte Ratio, Lymphocyte to Monocyte Ratio, and Platelet to Lymphocyte Ratio in Patients with Nasopharyngeal Carcinoma.
Lu A; Li H; Zheng Y; Tang M; Li J; Wu H; Zhong W; Gao J; Ou N; Cai Y
Biomed Res Int; 2017; 2017():3047802. PubMed ID: 28321405
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of immunotherapy-induced inflammation indexes: dynamic changes in patients with nasopharyngeal carcinoma receiving immune checkpoint inhibitors.
Cao J; Chen Q; Bai X; Liu L; Ma W; Lin C; Lu F; Zhou T; Zhan J; Huang Y; Yang Y; Luo F; Zhao H
Ann Med; 2023; 55(2):2280002. PubMed ID: 38065623
[TBL] [Abstract][Full Text] [Related]
14. Cutoff point of neutrophil-to-lymphocyte ratio for predicting survival in nasopharyngeal carcinoma.
Setakornnukul J; Chanvimalueng W; Patumanond J; Thephamongkhol K
Medicine (Baltimore); 2021 Aug; 100(34):e27095. PubMed ID: 34449514
[TBL] [Abstract][Full Text] [Related]
15. Nomogram based on pre-treatment inflammatory biomarkers predicting survival in patients with head and neck soft tissue sarcoma.
Chen L; Zeng H; Du Z; Zhao Y; Ma X
Cancer Biomark; 2020; 29(1):151-161. PubMed ID: 32623392
[TBL] [Abstract][Full Text] [Related]
16. Nomograms based on the lymphocyte-albumin-neutrophil ratio (LANR) for predicting the prognosis of nasopharyngeal carcinoma patients after definitive radiotherapy.
Zhang S; Chen Z; Ling J; Feng Y; Xie Y; Liu X; Hu C; Hou T
Sci Rep; 2024 Mar; 14(1):5388. PubMed ID: 38443675
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of pre-treatment neutrophil-to-lymphocyte ratio (NLR) in nasopharyngeal carcinoma: A retrospective study of 180 Taiwanese patients.
Liao LJ; Hsu WL; Wang CT; Lo WC; Cheng PW; Shueng PW; Hsieh CH; Chiu YL; Lin YC
Clin Otolaryngol; 2018 Apr; 43(2):463-469. PubMed ID: 28950051
[TBL] [Abstract][Full Text] [Related]
18. A nomogram combining inflammatory markers and clinical factors predicts survival in patients with diffuse glioma.
Yan P; Li JW; Mo LG; Huang QR
Medicine (Baltimore); 2021 Nov; 100(47):e27972. PubMed ID: 34964788
[TBL] [Abstract][Full Text] [Related]
19. A novel nomogram to predict survival in patients with recurrent nasopharyngeal carcinoma after salvage endoscopic surgery.
Li W; Lu H; Liu J; Liu Q; Wang H; Zhang H; Hu L; Zhao W; Gu Y; Li H; Sun X; Wang D
Oral Oncol; 2020 Dec; 111():104922. PubMed ID: 32712576
[TBL] [Abstract][Full Text] [Related]
20. Prognosis viewing for nasopharyngeal carcinoma treated with intensity-modulated radiation therapy: application of nomogram and decision curve analysis.
Fei Z; Qiu X; Li M; Chen C; Li Y; Huang Y
Jpn J Clin Oncol; 2020 Feb; 50(2):159-168. PubMed ID: 31711182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
